{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:07Z","timestamp":1792786147272,"version":"4.5.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["No.82360937"],"award-info":[{"award-number":["No.82360937"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Guangxi Natural Science Foundation of China","award":["No.2023GXNSFAA026075"],"award-info":[{"award-number":["No.2023GXNSFAA026075"]}]},{"name":"Guangxi Traditional Chinese Medicine Interdisciplinary Innovation Team Project","award":["GZKJ2310"],"award-info":[{"award-number":["GZKJ2310"]}]},{"name":"Huang You-rong Guangxi TCM Master Training Program","award":["(Project No.Guangxi TCM Science and Education Development [2022] No.6"],"award-info":[{"award-number":["(Project No.Guangxi TCM Science and Education Development [2022] No.6"]}]},{"name":"Guangxi University of Traditional Chinese Medicine Youth Innovation Research Team Project","award":["No. 2021TD001"],"award-info":[{"award-number":["No. 2021TD001"]}],"id":[{"id":"https:\/\/ror.org\/03jy32q83","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Guangxi University of Traditional Chinese Medicine Introduction of Doctoral Research Fund Project","award":["2023BS042"],"award-info":[{"award-number":["2023BS042"]}],"id":[{"id":"https:\/\/ror.org\/03jy32q83","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Guangxi Young Qi Huang Scholar Training Project","award":["Guangxi TCM Medicine Science Education Development [2022] No. 13"],"award-info":[{"award-number":["Guangxi TCM Medicine Science Education Development [2022] No. 13"]}]},{"name":"Guangxi Young Qi Huang Scholar Training Project; Construction Project of Guangxi Key Research Laboratory of Traditional Chinese Medicine","award":["Science and Education Development of Traditional Chinese Medicine in Guangxi [2023]9"],"award-info":[{"award-number":["Science and Education Development of Traditional Chinese Medicine in Guangxi [2023]9"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Postmenopausal osteoporosis (PMOP) is a metabolic bone disease characterized by decreased bone mass and deteriorated bone microstructure. Despite advancements in hormone-related PMOP research, a systematic bibliometric analysis in this domain remains absent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study employs bibliometric methods to delineate global trends, key contributors, and research hotspots in PMOP-related hormone studies (2004\u20132024), providing evidence-based guidance for future investigations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design:<\/jats:title>\n                    <jats:p>A comprehensive analysis was conducted using 2004 to 2024 literature systematically retrieved from the Web of Science Core Collection database, focusing on PMOP-hormone interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      CiteSpace (6.3.R1) facilitated multidimensional analyses of countries, institutions, authors, journals, co-cited references, and keywords. Network optimization utilized\n                      <jats:italic toggle=\"yes\">g<\/jats:italic>\n                      -index (\n                      <jats:italic toggle=\"yes\">k<\/jats:italic>\n                      \u2005=\u200525) node filtering and the PathFinder algorithm for structural refinement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 7174 analyzed publications, China and the United States dominated research output (46.94% combined). Leading institutions included the University of California System and Harvard University, with Osteoporosis International as the most active journal. Keyword clustering revealed emerging hotspots: oxidative stress (cluster #0), vitamin D deficiency, and romosozumab, demonstrating the centrality of estrogen receptor-related studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This pioneering bibliometric study establishes a knowledge mapping framework for PMOP-hormone research, elucidating multidimensional associations between hormonal regulation and bone metabolism. Findings underscore oxidative stress-hormone axis modulation and romosozumab-targeted therapies as critical frontiers, while emphasizing the imperative for enhanced interdisciplinary collaboration to advance therapeutic innovation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049688","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:02:23Z","timestamp":1783720943000},"page":"e49688","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Visual analysis of the literature on postmenopausal osteoporosis-related hormone research: Current status and future trends (2004\u20132024)"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5559-8358","authenticated-orcid":false,"given":"Yongjin","family":"Li","sequence":"first","affiliation":[{"name":"Graduate School of Guangxi University of Chinese Medicine, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jin","sequence":"additional","affiliation":[{"name":"Graduate School of Guangxi University of Chinese Medicine, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunjian","family":"Li","sequence":"additional","affiliation":[{"name":"Graduate School of Guangxi University of Chinese Medicine, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyi","family":"Zou","sequence":"additional","affiliation":[{"name":"Graduate School of Guangxi University of Chinese Medicine, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-9508","authenticated-orcid":false,"given":"Lin","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Joint Surgery, Guangxi Orthopaedic Hospital, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","article-title":"Postmenopausal osteoporosis.","volume":"389","author":"Walker","year":"2023","journal-title":"N Engl J Med"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"3686749","DOI":"10.1155\/2020\/3686749","article-title":"The interplay between immune system and microbiota in osteoporosis.","volume":"2020","author":"Locantore","year":"2020","journal-title":"Mediators Inflamm"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.33549\/physiolres.934509","article-title":"What is a hormone?","volume":"69","author":"St\u00e1rka","year":"2020","journal-title":"Physiol Res"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"1372399","DOI":"10.3389\/fphar.2024.1372399","article-title":"Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis.","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"e20362","DOI":"10.1016\/j.heliyon.2023.e20362","article-title":"Global research trends of immunosenescence: a bibliometric study.","volume":"9","author":"Chen","year":"2023","journal-title":"Heliyon"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"1466156","DOI":"10.3389\/fphar.2024.1466156","article-title":"The mechanisms and drug therapies of colorectal cancer and epigenetics: bibliometrics and visualized analysis.","volume":"15","author":"Tian","year":"2024","journal-title":"Front Pharmacol"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"1309688","DOI":"10.3389\/fbioe.2023.1309688","article-title":"Harnessing joint distraction for the treatment of osteoarthritis: a bibliometric and visualized analysis.","volume":"11","author":"Peng","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.3748\/wjg.v29.i37.5339","article-title":"Global trends and hotspots of treatment for nonalcoholic fatty liver disease: a bibliometric and visualization analysis (2010-2023).","volume":"29","author":"Dai","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/os.14133","article-title":"Global trends in research of programmed cell death in osteoporosis: a bibliometric and visualized analysis (2000\u20132023).","volume":"16","author":"Rong","year":"2024","journal-title":"Orthop Surg"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial.","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial.","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis.","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis.","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N Engl J Med"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2019s Health Initiative randomized trial.","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","article-title":"Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX\u2122 and the assessment of fracture probability in men and women from the UK.","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3\u2010year, randomized, placebo\u2010, and active\u2010controlled clinical trial.","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density.","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00198-015-3037-x","article-title":"Erratum to: clinician\u2019s guide to prevention and treatment of osteoporosis.","volume":"26","author":"Cosman","year":"2015","journal-title":"Osteoporos Int"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","article-title":"Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.","volume":"386","author":"Leder","year":"2015","journal-title":"Lancet"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis.","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","article-title":"Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.","volume":"391","author":"Kendler","year":"2018","journal-title":"Lancet"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an endocrine society clinical practice guideline.","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women.","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis.","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2174\/1871530323666230330121301","article-title":"Endocrine, metabolic, and immune pathogenesis of postmenopausal osteoporosis. Is there a therapeutic role in natural products?","volume":"23","author":"Lisco","year":"2023","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R36-20261001","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/med.22081","article-title":"Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis.","volume":"45","author":"Yao","year":"2025","journal-title":"Med Res Rev"},{"key":"R37-20261001","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.3390\/ijms25137247","article-title":"Korean black goat extract exerts estrogen-like osteoprotective effects by stimulating osteoblast differentiation in MC3T3-E1 cells and suppressing osteoclastogenesis in RAW 264.7 cells.","volume":"25","author":"Akter","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R38-20261001","doi-asserted-by":"crossref","first-page":"117173","DOI":"10.1016\/j.bone.2024.117173","article-title":"Estrogen deficiency induces changes in bone matrix bound water that do not closely correspond with bone turnover.","volume":"186","author":"Metzger","year":"2024","journal-title":"Bone"},{"key":"R39-20261001","first-page":"336","article-title":"A two-pronged approach to inhibit ferroptosis of MSCs caused by the iron overload in postmenopausal osteoporosis and promote osseointegration of titanium implant.","volume":"41","author":"Yang","year":"2024","journal-title":"Bioact Mater"},{"key":"R40-20261001","doi-asserted-by":"crossref","first-page":"112893","DOI":"10.1016\/j.intimp.2024.112893","article-title":"Cardamonin attenuates iron overload-induced osteoblast oxidative stress through the HIF-1\u03b1\/ROS pathway.","volume":"142","author":"Chen","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R41-20261001","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1530\/EOR-23-0148","article-title":"An update on the role of ferroptosis in the pathogenesis of osteoporosis.","volume":"9","author":"Wu","year":"2024","journal-title":"EFORT Open Rev"},{"key":"R42-20261001","doi-asserted-by":"crossref","first-page":"706747","DOI":"10.3389\/fphar.2021.706747","article-title":"Osteoprotective effects in postmenopausal osteoporosis rat model: oral tocotrienol vs. intraosseous injection of tocotrienol-poly lactic-co-glycolic acid combination.","volume":"12","author":"Ibrahim","year":"2021","journal-title":"Front Pharmacol"},{"key":"R43-20261001","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.3390\/ijms24043772","article-title":"Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs.","volume":"24","author":"Iantomasi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R44-20261001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2147\/IJWH.S409897","article-title":"Nutrition-based support for osteoporosis in postmenopausal women: a review of recent evidence.","volume":"16","author":"Alabadi","year":"2024","journal-title":"Int J Womens Health"},{"key":"R45-20261001","doi-asserted-by":"crossref","first-page":"22162","DOI":"10.1038\/s41598-024-73014-6","article-title":"A comparative study of hormonal contraceptive use and vitamin D levels at Gondar Town 2023.","volume":"14","author":"Chane","year":"2024","journal-title":"Sci Rep"},{"key":"R46-20261001","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/nu16162679","article-title":"Target values for 25-hydroxy and 1, 25-dihydroxy vitamin D based on their associations with inflammation and calcium-phosphate metabolism.","volume":"16","author":"Li","year":"2024","journal-title":"Nutrients"},{"key":"R47-20261001","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2020.05.020","article-title":"Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health.","volume":"140","author":"Capozzi","year":"2020","journal-title":"Maturitas"},{"key":"R48-20261001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00774-024-01536-0","article-title":"Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis.","volume":"43","author":"Ebina","year":"2025","journal-title":"J Bone Miner Metab"},{"key":"R49-20261001","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00223-024-01261-w","article-title":"The relationship between sclerostin and kidney transplantation mineral bone disorders: a molecule of controversies.","volume":"115","author":"Afsar","year":"2024","journal-title":"Calcif Tissue Int"},{"key":"R50-20261001","doi-asserted-by":"crossref","first-page":"1168757","DOI":"10.3389\/fendo.2023.1168757","article-title":"Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: a randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial.","volume":"14","author":"Dai","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R51-20261001","doi-asserted-by":"crossref","first-page":"102522","DOI":"10.1016\/j.tice.2024.102522","article-title":"Sclerostin inhibits Protein kinase C inhibitor G\u00d66976 induced osteogenic differentiation of dental follicle cells.","volume":"90","author":"De Pellegrin","year":"2024","journal-title":"Tissue Cell"},{"key":"R52-20261001","doi-asserted-by":"crossref","first-page":"e181940","DOI":"10.1172\/jci.insight.181940","article-title":"Sclerostin antibody corrects periodontal disease in type 2 diabetic mice.","volume":"9","author":"Turkkahraman","year":"2024","journal-title":"JCI Insight"},{"key":"R53-20261001","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.3390\/ijms23094895","article-title":"Positive and negative regulators of sclerostin expression.","volume":"23","author":"Iwamoto","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:01:57Z","timestamp":1790881317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":53,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049688","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2025-07-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}